 | • レポートコード：QAF27710 • 出版社/出版日：QYResearch / 2021年4月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の止血剤市場について種類別（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他）、用途別（病院、外科センター、ナーシングホーム）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・止血剤市場の概要 ・世界の主要地域別止血剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の止血剤市場規模2016-2021：種類別（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他） ・世界の止血剤市場予測2012-2027：種類別（ゲル化スポンジ、酸化再生セルロース系止血鉗子、その他） ・世界の止血剤市場規模2016-2021：用途別（病院、外科センター、ナーシングホーム） ・世界の止血剤市場予測2012-2027：用途別（病院、外科センター、ナーシングホーム） ・止血剤のアメリカ市場規模と予測2016-2021 ・止血剤のヨーロッパ市場規模と予測2016-2021 ・止血剤の中国市場規模と予測2016-2021 ・止血剤の日本市場規模と予測2016-2021 ・止血剤の東南アジア市場規模と予測2016-2021 ・止血剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Ethicon、Pfizer、Baxter International、C. R. Bard、The Medicines Company、Anika Therapeutics、Advanced Medical Solutions、Integra LifeSciences、B Braun Melsungen、Gelita Medical、Equimedical、Vascular Solutions、Marine Polymer Technologies、Z-Medica、CryoLife、BioCer Entwicklungs、Biom’Up SAS） ・止血剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・止血剤の市場動向・機会・課題 ・調査の結論 |
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Market Analysis and Insights: Global Hemostatic Agents Market
The global Hemostatic Agents market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Hemostatic Agents Scope and Market Size
The global Hemostatic Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
The Hemostatic Agents market is analysed and market size information is provided by regions (countries). Segment by Application, the Hemostatic Agents market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
1 Hemostatic Agents Market Overview
1.1 Hemostatic Agents Product Scope
1.2 Hemostatic Agents Segment by Type
1.2.1 Global Hemostatic Agents Sales by Type (2016 & 2021 & 2027)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Hemostatic Agents Segment by Application
1.3.1 Global Hemostatic Agents Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Hemostatic Agents Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hemostatic Agents Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hemostatic Agents Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hemostatic Agents Price Trends (2016-2027)
2 Hemostatic Agents Estimates and Forecasts by Region
2.1 Global Hemostatic Agents Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hemostatic Agents Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hemostatic Agents Sales Market Share by Region (2016-2021)
2.2.2 Global Hemostatic Agents Revenue Market Share by Region (2016-2021)
2.3 Global Hemostatic Agents Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hemostatic Agents Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hemostatic Agents Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hemostatic Agents Estimates and Projections (2016-2027)
2.4.2 Europe Hemostatic Agents Estimates and Projections (2016-2027)
2.4.3 China Hemostatic Agents Estimates and Projections (2016-2027)
2.4.4 Japan Hemostatic Agents Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hemostatic Agents Estimates and Projections (2016-2027)
2.4.6 India Hemostatic Agents Estimates and Projections (2016-2027)
3 Global Hemostatic Agents Competition Landscape by Players
3.1 Global Top Hemostatic Agents Players by Sales (2016-2021)
3.2 Global Top Hemostatic Agents Players by Revenue (2016-2021)
3.3 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2020)
3.4 Global Hemostatic Agents Average Price by Company (2016-2021)
3.5 Manufacturers Hemostatic Agents Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hemostatic Agents Market Size by Type
4.1 Global Hemostatic Agents Historic Market Review by Type (2016-2021)
4.1.1 Global Hemostatic Agents Sales Market Share by Type (2016-2021)
4.1.2 Global Hemostatic Agents Revenue Market Share by Type (2016-2021)
4.1.3 Global Hemostatic Agents Price by Type (2016-2021)
4.2 Global Hemostatic Agents Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hemostatic Agents Sales Forecast by Type (2022-2027)
4.2.2 Global Hemostatic Agents Revenue Forecast by Type (2022-2027)
4.2.3 Global Hemostatic Agents Price Forecast by Type (2022-2027)
5 Global Hemostatic Agents Market Size by Application
5.1 Global Hemostatic Agents Historic Market Review by Application (2016-2021)
5.1.1 Global Hemostatic Agents Sales Market Share by Application (2016-2021)
5.1.2 Global Hemostatic Agents Revenue Market Share by Application (2016-2021)
5.1.3 Global Hemostatic Agents Price by Application (2016-2021)
5.2 Global Hemostatic Agents Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hemostatic Agents Sales Forecast by Application (2022-2027)
5.2.2 Global Hemostatic Agents Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemostatic Agents Price Forecast by Application (2022-2027)
6 North America Hemostatic Agents Market Facts & Figures
6.1 North America Hemostatic Agents Sales by Company
6.1.1 North America Hemostatic Agents Sales by Company (2016-2021)
6.1.2 North America Hemostatic Agents Revenue by Company (2016-2021)
6.2 North America Hemostatic Agents Sales Breakdown by Type
6.2.1 North America Hemostatic Agents Sales Breakdown by Type (2016-2021)
6.2.2 North America Hemostatic Agents Sales Breakdown by Type (2022-2027)
6.3 North America Hemostatic Agents Sales Breakdown by Application
6.3.1 North America Hemostatic Agents Sales Breakdown by Application (2016-2021)
6.3.2 North America Hemostatic Agents Sales Breakdown by Application (2022-2027)
7 Europe Hemostatic Agents Market Facts & Figures
7.1 Europe Hemostatic Agents Sales by Company
7.1.1 Europe Hemostatic Agents Sales by Company (2016-2021)
7.1.2 Europe Hemostatic Agents Revenue by Company (2016-2021)
7.2 Europe Hemostatic Agents Sales Breakdown by Type
7.2.1 Europe Hemostatic Agents Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hemostatic Agents Sales Breakdown by Type (2022-2027)
7.3 Europe Hemostatic Agents Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Hemostatic Agents Market Facts & Figures
8.1 China Hemostatic Agents Sales by Company
8.1.1 China Hemostatic Agents Sales by Company (2016-2021)
8.1.2 China Hemostatic Agents Revenue by Company (2016-2021)
8.2 China Hemostatic Agents Sales Breakdown by Type
8.2.1 China Hemostatic Agents Sales Breakdown by Type (2016-2021)
8.2.2 China Hemostatic Agents Sales Breakdown by Type (2022-2027)
8.3 China Hemostatic Agents Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Hemostatic Agents Market Facts & Figures
9.1 Japan Hemostatic Agents Sales by Company
9.1.1 Japan Hemostatic Agents Sales by Company (2016-2021)
9.1.2 Japan Hemostatic Agents Revenue by Company (2016-2021)
9.2 Japan Hemostatic Agents Sales Breakdown by Type
9.2.1 Japan Hemostatic Agents Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hemostatic Agents Sales Breakdown by Type (2022-2027)
9.3 Japan Hemostatic Agents Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hemostatic Agents Market Facts & Figures
10.1 Southeast Asia Hemostatic Agents Sales by Company
10.1.1 Southeast Asia Hemostatic Agents Sales by Company (2016-2021)
10.1.2 Southeast Asia Hemostatic Agents Revenue by Company (2016-2021)
10.2 Southeast Asia Hemostatic Agents Sales Breakdown by Type
10.2.1 Southeast Asia Hemostatic Agents Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hemostatic Agents Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hemostatic Agents Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Hemostatic Agents Market Facts & Figures
11.1 India Hemostatic Agents Sales by Company
11.1.1 India Hemostatic Agents Sales by Company (2016-2021)
11.1.2 India Hemostatic Agents Revenue by Company (2016-2021)
11.2 India Hemostatic Agents Sales Breakdown by Type
11.2.1 India Hemostatic Agents Sales Breakdown by Type (2016-2021)
11.2.2 India Hemostatic Agents Sales Breakdown by Type (2022-2027)
11.3 India Hemostatic Agents Sales Breakdown by Application
11.3.1 India Hemostatic Agents Sales Breakdown by Application (2016-2021)
11.3.2 India Hemostatic Agents Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hemostatic Agents Business
12.1 Ethicon
12.1.1 Ethicon Corporation Information
12.1.2 Ethicon Business Overview
12.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Ethicon Hemostatic Agents Products Offered
12.1.5 Ethicon Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Hemostatic Agents Products Offered
12.2.5 Pfizer Recent Development
12.3 Baxter International
12.3.1 Baxter International Corporation Information
12.3.2 Baxter International Business Overview
12.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Baxter International Hemostatic Agents Products Offered
12.3.5 Baxter International Recent Development
12.4 C. R. Bard
12.4.1 C. R. Bard Corporation Information
12.4.2 C. R. Bard Business Overview
12.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.4.4 C. R. Bard Hemostatic Agents Products Offered
12.4.5 C. R. Bard Recent Development
12.5 The Medicines Company
12.5.1 The Medicines Company Corporation Information
12.5.2 The Medicines Company Business Overview
12.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.5.4 The Medicines Company Hemostatic Agents Products Offered
12.5.5 The Medicines Company Recent Development
12.6 Anika Therapeutics
12.6.1 Anika Therapeutics Corporation Information
12.6.2 Anika Therapeutics Business Overview
12.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Anika Therapeutics Hemostatic Agents Products Offered
12.6.5 Anika Therapeutics Recent Development
12.7 Advanced Medical Solutions
12.7.1 Advanced Medical Solutions Corporation Information
12.7.2 Advanced Medical Solutions Business Overview
12.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Advanced Medical Solutions Hemostatic Agents Products Offered
12.7.5 Advanced Medical Solutions Recent Development
12.8 Integra LifeSciences
12.8.1 Integra LifeSciences Corporation Information
12.8.2 Integra LifeSciences Business Overview
12.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Integra LifeSciences Hemostatic Agents Products Offered
12.8.5 Integra LifeSciences Recent Development
12.9 B Braun Melsungen
12.9.1 B Braun Melsungen Corporation Information
12.9.2 B Braun Melsungen Business Overview
12.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.9.4 B Braun Melsungen Hemostatic Agents Products Offered
12.9.5 B Braun Melsungen Recent Development
12.10 Gelita Medical
12.10.1 Gelita Medical Corporation Information
12.10.2 Gelita Medical Business Overview
12.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Gelita Medical Hemostatic Agents Products Offered
12.10.5 Gelita Medical Recent Development
12.11 Equimedical
12.11.1 Equimedical Corporation Information
12.11.2 Equimedical Business Overview
12.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Equimedical Hemostatic Agents Products Offered
12.11.5 Equimedical Recent Development
12.12 Vascular Solutions
12.12.1 Vascular Solutions Corporation Information
12.12.2 Vascular Solutions Business Overview
12.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Vascular Solutions Hemostatic Agents Products Offered
12.12.5 Vascular Solutions Recent Development
12.13 Marine Polymer Technologies
12.13.1 Marine Polymer Technologies Corporation Information
12.13.2 Marine Polymer Technologies Business Overview
12.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Marine Polymer Technologies Hemostatic Agents Products Offered
12.13.5 Marine Polymer Technologies Recent Development
12.14 Z-Medica
12.14.1 Z-Medica Corporation Information
12.14.2 Z-Medica Business Overview
12.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Z-Medica Hemostatic Agents Products Offered
12.14.5 Z-Medica Recent Development
12.15 CryoLife
12.15.1 CryoLife Corporation Information
12.15.2 CryoLife Business Overview
12.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.15.4 CryoLife Hemostatic Agents Products Offered
12.15.5 CryoLife Recent Development
12.16 BioCer Entwicklungs
12.16.1 BioCer Entwicklungs Corporation Information
12.16.2 BioCer Entwicklungs Business Overview
12.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.16.4 BioCer Entwicklungs Hemostatic Agents Products Offered
12.16.5 BioCer Entwicklungs Recent Development
12.17 Biom’Up SAS
12.17.1 Biom’Up SAS Corporation Information
12.17.2 Biom’Up SAS Business Overview
12.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Biom’Up SAS Hemostatic Agents Products Offered
12.17.5 Biom’Up SAS Recent Development
13 Hemostatic Agents Manufacturing Cost Analysis
13.1 Hemostatic Agents Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hemostatic Agents
13.4 Hemostatic Agents Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hemostatic Agents Distributors List
14.3 Hemostatic Agents Customers
15 Market Dynamics
15.1 Hemostatic Agents Market Trends
15.2 Hemostatic Agents Drivers
15.3 Hemostatic Agents Market Challenges
15.4 Hemostatic Agents Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hemostatic Agents Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hemostatic Agents Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hemostatic Agents Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hemostatic Agents Sales (K Units) by Region (2016-2021)
Table 5. Global Hemostatic Agents Sales Market Share by Region (2016-2021)
Table 6. Global Hemostatic Agents Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hemostatic Agents Revenue Share by Region (2016-2021)
Table 8. Global Hemostatic Agents Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Hemostatic Agents Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hemostatic Agents Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hemostatic Agents Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hemostatic Agents Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Hemostatic Agents Sales Share by Company (2016-2021)
Table 14. Global Hemostatic Agents Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hemostatic Agents Revenue Share by Company (2016-2021)
Table 16. Global Hemostatic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic Agents as of 2020)
Table 17. Global Hemostatic Agents Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Hemostatic Agents Manufacturing Sites and Area Served
Table 19. Manufacturers Hemostatic Agents Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hemostatic Agents Sales (K Units) by Type (2016-2021)
Table 22. Global Hemostatic Agents Sales Share by Type (2016-2021)
Table 23. Global Hemostatic Agents Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hemostatic Agents Price (USD/Unit) by Type (2016-2021)
Table 25. Global Hemostatic Agents Sales Share by Type (2022-2027)
Table 26. Global Hemostatic Agents Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hemostatic Agents Revenue Share by Type (2022-2027)
Table 28. Global Hemostatic Agents Price (USD/Unit) by Type (2022-2027)
Table 29. Global Hemostatic Agents Sales (K Units) by Application (2016-2021)
Table 30. Global Hemostatic Agents Sales Share by Application (2016-2021)
Table 31. Global Hemostatic Agents Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hemostatic Agents Price (USD/Unit) by Application (2016-2021)
Table 33. Global Hemostatic Agents Sales (K Units) by Application (2022-2027)
Table 34. Global Hemostatic Agents Sales Share by Application (2022-2027)
Table 35. Global Hemostatic Agents Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hemostatic Agents Revenue Share by Application (2022-2027)
Table 37. Global Hemostatic Agents Price (USD/Unit) by Application (2022-2027)
Table 38. North America Hemostatic Agents Sales (K Units) by Company (2016-2021)
Table 39. North America Hemostatic Agents Sales Market Share by Company (2016-2021)
Table 40. North America Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hemostatic Agents Revenue Market Share by Company (2016-2021)
Table 42. North America Hemostatic Agents Sales by Type (2016-2021) & (K Units)
Table 43. North America Hemostatic Agents Sales Market Share by Type (2016-2021)
Table 44. North America Hemostatic Agents Sales by Type (2022-2027) & (K Units)
Table 45. North America Hemostatic Agents Sales Market Share by Type (2022-2027)
Table 46. North America Hemostatic Agents Sales by Application (2016-2021) & (K Units)
Table 47. North America Hemostatic Agents Sales Market Share by Application (2016-2021)
Table 48. North America Hemostatic Agents Sales by Application (2022-2027) & (K Units)
Table 49. North America Hemostatic Agents Sales Market Share by Application (2022-2027)
Table 50. Europe Hemostatic Agents Sales (K Units) by Company (2016-2021)
Table 51. Europe Hemostatic Agents Sales Market Share by Company (2016-2021)
Table 52. Europe Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hemostatic Agents Revenue Market Share by Company (2016-2021)
Table 54. Europe Hemostatic Agents Sales by Type (2016-2021) & (K Units)
Table 55. Europe Hemostatic Agents Sales Market Share by Type (2016-2021)
Table 56. Europe Hemostatic Agents Sales by Type (2022-2027) & (K Units)
Table 57. Europe Hemostatic Agents Sales Market Share by Type (2022-2027)
Table 58. Europe Hemostatic Agents Sales by Application (2016-2021) & (K Units)
Table 59. Europe Hemostatic Agents Sales Market Share by Application (2016-2021)
Table 60. Europe Hemostatic Agents Sales by Application (2022-2027) & (K Units)
Table 61. Europe Hemostatic Agents Sales Market Share by Application (2022-2027)
Table 62. China Hemostatic Agents Sales (K Units) by Company (2016-2021)
Table 63. China Hemostatic Agents Sales Market Share by Company (2016-2021)
Table 64. China Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hemostatic Agents Revenue Market Share by Company (2016-2021)
Table 66. China Hemostatic Agents Sales by Type (2016-2021) & (K Units)
Table 67. China Hemostatic Agents Sales Market Share by Type (2016-2021)
Table 68. China Hemostatic Agents Sales by Type (2022-2027) & (K Units)
Table 69. China Hemostatic Agents Sales Market Share by Type (2022-2027)
Table 70. China Hemostatic Agents Sales by Application (2016-2021) & (K Units)
Table 71. China Hemostatic Agents Sales Market Share by Application (2016-2021)
Table 72. China Hemostatic Agents Sales by Application (2022-2027) & (K Units)
Table 73. China Hemostatic Agents Sales Market Share by Application (2022-2027)
Table 74. Japan Hemostatic Agents Sales (K Units) by Company (2016-2021)
Table 75. Japan Hemostatic Agents Sales Market Share by Company (2016-2021)
Table 76. Japan Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hemostatic Agents Revenue Market Share by Company (2016-2021)
Table 78. Japan Hemostatic Agents Sales by Type (2016-2021) & (K Units)
Table 79. Japan Hemostatic Agents Sales Market Share by Type (2016-2021)
Table 80. Japan Hemostatic Agents Sales by Type (2022-2027) & (K Units)
Table 81. Japan Hemostatic Agents Sales Market Share by Type (2022-2027)
Table 82. Japan Hemostatic Agents Sales by Application (2016-2021) & (K Units)
Table 83. Japan Hemostatic Agents Sales Market Share by Application (2016-2021)
Table 84. Japan Hemostatic Agents Sales by Application (2022-2027) & (K Units)
Table 85. Japan Hemostatic Agents Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hemostatic Agents Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Hemostatic Agents Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hemostatic Agents Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hemostatic Agents Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Hemostatic Agents Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hemostatic Agents Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Hemostatic Agents Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hemostatic Agents Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Hemostatic Agents Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hemostatic Agents Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Hemostatic Agents Sales Market Share by Application (2022-2027)
Table 98. India Hemostatic Agents Sales (K Units) by Company (2016-2021)
Table 99. India Hemostatic Agents Sales Market Share by Company (2016-2021)
Table 100. India Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hemostatic Agents Revenue Market Share by Company (2016-2021)
Table 102. India Hemostatic Agents Sales by Type (2016-2021) & (K Units)
Table 103. India Hemostatic Agents Sales Market Share by Type (2016-2021)
Table 104. India Hemostatic Agents Sales by Type (2022-2027) & (K Units)
Table 105. India Hemostatic Agents Sales Market Share by Type (2022-2027)
Table 106. India Hemostatic Agents Sales by Application (2016-2021) & (K Units)
Table 107. India Hemostatic Agents Sales Market Share by Application (2016-2021)
Table 108. India Hemostatic Agents Sales by Application (2022-2027) & (K Units)
Table 109. India Hemostatic Agents Sales Market Share by Application (2022-2027)
Table 110. Ethicon Corporation Information
Table 111. Ethicon Description and Business Overview
Table 112. Ethicon Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Ethicon Hemostatic Agents Product
Table 114. Ethicon Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Pfizer Hemostatic Agents Product
Table 119. Pfizer Recent Development
Table 120. Baxter International Corporation Information
Table 121. Baxter International Description and Business Overview
Table 122. Baxter International Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Baxter International Hemostatic Agents Product
Table 124. Baxter International Recent Development
Table 125. C. R. Bard Corporation Information
Table 126. C. R. Bard Description and Business Overview
Table 127. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. C. R. Bard Hemostatic Agents Product
Table 129. C. R. Bard Recent Development
Table 130. The Medicines Company Corporation Information
Table 131. The Medicines Company Description and Business Overview
Table 132. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. The Medicines Company Hemostatic Agents Product
Table 134. The Medicines Company Recent Development
Table 135. Anika Therapeutics Corporation Information
Table 136. Anika Therapeutics Description and Business Overview
Table 137. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Anika Therapeutics Hemostatic Agents Product
Table 139. Anika Therapeutics Recent Development
Table 140. Advanced Medical Solutions Corporation Information
Table 141. Advanced Medical Solutions Description and Business Overview
Table 142. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Advanced Medical Solutions Hemostatic Agents Product
Table 144. Advanced Medical Solutions Recent Development
Table 145. Integra LifeSciences Corporation Information
Table 146. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Integra LifeSciences Description and Business Overview
Table 148. Integra LifeSciences Hemostatic Agents Product
Table 149. Integra LifeSciences Recent Development
Table 150. B Braun Melsungen Corporation Information
Table 151. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. B Braun Melsungen Description and Business Overview
Table 153. B Braun Melsungen Hemostatic Agents Product
Table 154. B Braun Melsungen Recent Development
Table 155. Gelita Medical Corporation Information
Table 156. Gelita Medical Description and Business Overview
Table 157. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Gelita Medical Hemostatic Agents Product
Table 159. Gelita Medical Recent Development
Table 160. Equimedical Corporation Information
Table 161. Equimedical Description and Business Overview
Table 162. Equimedical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Equimedical Hemostatic Agents Product
Table 164. Equimedical Recent Development
Table 165. Vascular Solutions Corporation Information
Table 166. Vascular Solutions Description and Business Overview
Table 167. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Vascular Solutions Hemostatic Agents Product
Table 169. Vascular Solutions Recent Development
Table 170. Marine Polymer Technologies Corporation Information
Table 171. Marine Polymer Technologies Description and Business Overview
Table 172. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Marine Polymer Technologies Hemostatic Agents Product
Table 174. Marine Polymer Technologies Recent Development
Table 175. Z-Medica Corporation Information
Table 176. Z-Medica Description and Business Overview
Table 177. Z-Medica Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Z-Medica Hemostatic Agents Product
Table 179. Z-Medica Recent Development
Table 180. CryoLife Corporation Information
Table 181. CryoLife Description and Business Overview
Table 182. CryoLife Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. CryoLife Hemostatic Agents Product
Table 184. CryoLife Recent Development
Table 185. BioCer Entwicklungs Corporation Information
Table 186. BioCer Entwicklungs Description and Business Overview
Table 187. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. BioCer Entwicklungs Hemostatic Agents Product
Table 189. BioCer Entwicklungs Recent Development
Table 190. Biom’Up SAS Corporation Information
Table 191. Biom’Up SAS Description and Business Overview
Table 192. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 193. Biom’Up SAS Hemostatic Agents Product
Table 194. Biom’Up SAS Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Hemostatic Agents Distributors List
Table 198. Hemostatic Agents Customers List
Table 199. Hemostatic Agents Market Trends
Table 200. Hemostatic Agents Market Drivers
Table 201. Hemostatic Agents Market Challenges
Table 202. Hemostatic Agents Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Agents Product Picture
Figure 2. Global Hemostatic Agents Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hemostatic Agents Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Surgical Centers Examples
Figure 8. Nursing Homes Examples
Figure 9. Global Hemostatic Agents Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hemostatic Agents Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Hemostatic Agents Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Hemostatic Agents Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Hemostatic Agents Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Hemostatic Agents Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Hemostatic Agents Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Hemostatic Agents Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Hemostatic Agents Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Hemostatic Agents Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Hemostatic Agents Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Hemostatic Agents Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Hemostatic Agents Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Hemostatic Agents Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Hemostatic Agents Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Hemostatic Agents Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Hemostatic Agents Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Hemostatic Agents Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Hemostatic Agents Players Market Share by Revenue in Hemostatic Agents: 2016 & 2020
Figure 28. Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Hemostatic Agents Revenue Share by Type (2016-2021)
Figure 30. Global Hemostatic Agents Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Hemostatic Agents Revenue Share by Application (2016-2021)
Figure 32. Global Hemostatic Agents Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Hemostatic Agents Sales Market Share by Type in 2020
Figure 34. North America Hemostatic Agents Sales Market Share by Application in 2020
Figure 35. Europe Hemostatic Agents Sales Market Share by Type in 2020
Figure 36. Europe Hemostatic Agents Sales Market Share by Application in 2020
Figure 37. China Hemostatic Agents Sales Market Share by Type in 2020
Figure 38. China Hemostatic Agents Sales Market Share by Application in 2020
Figure 39. Japan Hemostatic Agents Sales Market Share by Type in 2020
Figure 40. Japan Hemostatic Agents Sales Market Share by Application in 2020
Figure 41. Southeast Asia Hemostatic Agents Sales Market Share by Type in 2020
Figure 42. Southeast Asia Hemostatic Agents Sales Market Share by Application in 2020
Figure 43. India Hemostatic Agents Sales Market Share by Type in 2020
Figure 44. India Hemostatic Agents Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Hemostatic Agents
Figure 47. Manufacturing Process Analysis of Hemostatic Agents
Figure 48. Hemostatic Agents Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の可吸収性止血剤市場規模・現状・予測（2021年-2027年） Absorbable hemostatic material is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period of time. Market Analysis and Insights: Global Absorbable Hemostatic Materials Market The global Absorbable Hemostatic Materials market s…- 世界の生分解性止血剤市場規模・現状・予測（2021年-2027年） Biodegradable hemostatic agent is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period of time. Market Analysis and Insights: Global Biodegradable Hemostatic Agent Market The global Biodegradable Hemostatic Agent market siz…
- 非侵襲性止血閉鎖デバイスのグローバル市場調査 2019年 The global Non-Invasive Hemostatic Closure Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non-Invasive Hemostatic Closure Devices volume and value at global level, regional level and compan…
- 外部止血装置のグローバル市場調査 2019年 The global External Hemostatic Device market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on External Hemostatic Device volume and value at global level, regional level and company level. From a global per…
- 世界の経口抗糖尿病剤市場規模・現状・予測（2021年-2027年） Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhi…